Derniers ajouts - Macular Diseases - Acquired
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 153 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 130 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 147 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 74 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 72 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 90 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 89 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 94 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 65 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 93 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 92 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 106 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 104 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 100 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
MacTel with foveal atrophy in both eyesvu 95 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 68 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 94 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 101 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 92 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 97 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 118 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 82 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 89 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 87 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 91 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 91 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 101 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 84 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 112 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
Latanoprost induced CMEvu 134 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 129 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 122 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 133 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 149 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 141 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 125 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 139 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 118 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 115 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 130 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 125 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 146 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 124 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 114 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 121 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 117 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 117 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 117 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 120 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 116 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 126 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 124 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 125 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 129 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 154 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 110 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 122 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 102 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 135 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Hydroxychloroquine Toxicityvu 149 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 176 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 191 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 172 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 154 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 151 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 155 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 201 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 211 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 165 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Pseudophakic CME chronicvu 125 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 155 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 154 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 169 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 165 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 178 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 169 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 185 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 174 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 162 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 160 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 188 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 155 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 187 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 163 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 163 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 137 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 151 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 186 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 185 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 135 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 162 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 174 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 170 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 186 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 182 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 130 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 161 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 165 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 181 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 139 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
| 2319 photos sur 24 page(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
